SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.

J A CrouzenA L PetoukhovaM L D BroekmanM FioccoU J FisscherJ H FranssenC G M Gadellaa-van HooijdonkM KerkhofM KiderlenM E MastC M van RijR Nandoe TewarieM A E van de SandeP P G van der ToornR VlasmanM J VosN C M G van der Voort van ZypR G J WiggenraadL M WiltinkJaap D Zindler

Published in: BMC cancer (2023)

ClincalTrials.gov, trial registration number: NCT05346367 , trial registration date: 26 April 2022.

Keyphrases

phase ii
brain metastases
clinical trial
open label
phase iii
small cell lung cancer
placebo controlled
double blind
study protocol
randomized controlled trial